Dare Bioscience Stock Quote DARE - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

3.60

Bid

3.51

Ask

3.83

Volume

14,720

3.59 Day's Range 3.64

3.05 52 Week Range 9.576

Market Cap

30.328M

Previous Close

3.64

Open

3.64

Last Trade

3.51

Last Trade Time

Financial Volume

$ 53,130

VWAP

3.6094

Average Volume (3m)

453,262

Shares Outstanding

8,424,408

Dividend Yield

PE Ratio

-1.01

Earnings Per Share (EPS)

-3.58

Revenue

2.81M

Net Profit

-30.16M

Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve... Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, primarily in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.darebioscience.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Dare Bioscience Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DARE. The last closing price for Dare Bioscience was $3.64. Over the last year, Dare Bioscience shares have traded in a share price range of $ 3.05 to $ 9.576.

Dare Bioscience currently has 8,424,408 shares outstanding. The market capitalization of Dare Bioscience is $30.66 million. Dare Bioscience has a price to earnings ratio (PE ratio) of -1.01.

Daré Bioscience Announces Publication in Obstetrics & Gynecology of Phase 2b Study Efficacy Results of Topical Sildenafil Cream, 3.6% for the Treatment of Female Sexual Arousal Disorder

Phase 2b study demonstrated topical Sildenafil Cream, 3.6% improved outcomes among women with female sexual arousal disorder (FSAD), particularly in an exploratory subset of women with FSAD with...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.1801	5.26623585485	3.4199	3.855	3.18	53834	3.52056441	CS
4	-1.6788	-31.8026824278	5.2788	5.64	3.05	316620	4.18162451	CS
12	-0.24	-6.25	3.84	7.56	3.05	453262	4.81411012	CS
26	-0.12	-3.22580645161	3.72	7.56	3.05	533598	4.69067855	CS
52	-5.976	-62.4060150376	9.576	9.576	3.05	470325	4.84133022	CS
156	-14.16	-79.7297297297	17.76	30.12	3.05	1234229	18.0681908	CS
260	-5.64	-61.038961039	9.24	46.2	3.05	1493410	19.64815833	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NUZENuZee Inc	$ 3.2954 (219.94%)	135.82M
DRMADermata Therapeutics Inc	$ 2.55 (96.15%)	65.31M
PIRSPieris Pharmaceuticals Inc	$ 14.9491 (87.33%)	5.85M
SLNASelina Hospitality PLC	$ 0.0456 (75.38%)	1.22B
QXOQXO Inc	$ 119.99 (51.31%)	218.2k
NXTTNext Technology Holding Inc	$ 2.50 (-57.04%)	965.73k
NUWENewellis Inc	$ 2.48 (-40.24%)	1.01M
LITMSnow Lake Resources Ltd	$ 0.625 (-35.43%)	5.76M
VWEVintage Wine Estates Inc	$ 0.0732 (-34.58%)	37.22M
CONNConns Inc	$ 0.345 (-31.95%)	4.45M
SLNASelina Hospitality PLC	$ 0.0456 (75.38%)	1.22B
NVDANVIDIA Corporation	$ 114.25 (-6.80%)	327.86M
SGMOSangamo Therapeutics Inc	$ 0.5584 (39.15%)	263.13M
SQQQProShares UltraPro Short QQQ	$ 9.06 (10.76%)	203.95M
TSLATesla Inc	$ 215.99 (-12.33%)	168.55M